Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

Healthcare executives understand the importance of patient acquisition but know it is challenging as patients split their care across multiple provider networks annually. In addition, changing consumer expectations, technological advances, and new, non-industry players all contribute to a highly competitive healthcare marketplace. To compete and stand out, health systems and hospitals must consider themselves consumer-facing…

A comprehensive pharmaceutical marketing strategy requires a thoughtful approach that encompasses both healthcare providers (HCPs) and consumers. However, achieving this integration effectively amidst the often segmented landscape of targeting can be challenging. This webinar addresses these challenges and offers insights to pharma marketers, agencies, and ad tech partners on how to leverage aggregated social determinants…

Impact of Applying SDOH on Prescription Fill Rate Analysis Life Sciences This whitepaper highlights the significance of understanding prescription rejection rates, particularly for specialty pharmacy medications, and the role of plan design and social determinants of health (SDOH) in determining eligibility and out-of-pocket costs for patients.   Traditional analyses focusing solely on demographics like age and…

  Prescription Measurement Report Gain a comprehensive view of a broad range of prescription analytics and fully analyze a prescription market. Segment markets by individual providers, group practices and geography with a single report. Watch the video to learn more about what you can do with Prescription Measurement Report.     https://vimeo.com/929564870

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic…

  Digital Innovations for Patient-Centered Clinical Trials Using Real-World Data Supporting the inclusion of underrepresented populations in clinical trials and real-world data studies requires a multi-faceted approach – access to real-world data sources supports decision-making to ensure diverse populations are considered proactively throughout research study phases. This presentation done by PurpleLab an Parexel during SCOPE…

Real-world data (RWD) is everywhere. In fact, your company likely already has access to a plethora of RWD. How are you using it to enhance your oncology clinical trial planning – and drive more positive patient outcomes?

New Treatments Hold Significant Promise, but are Marketing Teams Helping Life Sciences Companies Deliver on this Potential? Life Sciences Download